James Wrobel, DPM, MS, Receives the American Diabetes Association’s® 2019 Roger Pecoraro Award
May 24, 2019
James Wrobel, DPM, MS, has been selected to receive the American Diabetes Association’s® (ADA’s) 2019 Roger Pecoraro Award. This award recognizes a researcher who has made significant scientific contributions and demonstrates an untiring commitment to improving the understanding of the detection, treatment, and prevention of diabetic foot complications. Dr. Wrobel will be recognized with this honor during the ADA’s 79th Scientific Sessions, June 7-11, 2019, at the Moscone Convention Center in San Francisco. He will deliver the Roger Pecoraro Award Lecture, “Artificial Intelligence for Predicting Diabetes-Related Foot Ulcer Outcomes,” on Saturday, June 8.
Currently, Dr. Wrobel is a Clinical Associate Professor in the Division of Metabolism, Endocrinology, and Diabetes at the University of Michigan. He also serves as a Staff Podiatrist at the VA Ann Arbor Healthcare System in Ann Arbor, Michigan. His efforts include pioneering machine learning and image analysis methods that predict foot ulcerating and healing, exploring novel risk factors for Charcot neuroarthropathy, and understanding and reducing racial disparities in rates of diabetes-related amputations in the U.S.
“Dr. Wrobel’s research, which has focused on the pathophysiology, prevention, and treatment of diabetes-related foot complications and their broader context, has significantly enhanced the understanding of diabetic foot care,” said the ADA’s 2019 President of Medicine and Science Louis H. Philipson, MD, PhD, FACP. “Thank you, Dr. Wrobel, for your ongoing commitment to improving outcomes for people with diabetes, and congratulations on this award.”
An internationally recognized researcher and clinician, Dr. Wrobel has held volunteer leadership roles in various organizations. He has served as an active member of the American Diabetes Association’s Research Grant Review Committee, as well as a reviewer of ADA’s journal, Diabetes Care, and is a current member of the American Podiatric Medical Association’s Clinical Practice Committee.
The American Diabetes Association’s 79th Scientific Sessions, the world’s largest scientific meeting focused on diabetes research, prevention and care, will be held June 7-11, 2019, at the Moscone Center in San Francisco, California. Nearly 15,000 leading physicians, scientists, health care professionals and industry representatives from around the world are expected to convene at the Scientific Sessions to unveil cutting-edge research, treatment recommendations and advances toward a cure for diabetes. During the five-day meeting, attendees will receive exclusive access to more than 850 presentations and 2,000 original research presentations, participate in provocative and engaging exchanges with leading diabetes experts, and can earn Continuing Medical Education (CME) or Continuing Education (CE) credits for educational sessions. The program is grouped into eight thematic areas: Acute and Chronic Complications; Behavioral Medicine, Clinical Nutrition, Education and Exercise; Clinical Diabetes/Therapeutics; Epidemiology/Genetics; Immunology/Transplantation; Insulin Action/Molecular Metabolism; Integrated Physiology/Obesity; and Islet Biology/Insulin Secretion. Gretchen Youssef, MS, RDN, CDE, President of Health Care and Education, will deliver her address, “It’s All about Access!,” on Saturday, June 8, and Louis H. Philipson, MD, PhD, FACP, President of Medicine and Science, will deliver his lecture, “Precision Medicine—Addressing the Many Faces of Diabetes,” on Sunday, June 9. Join the Scientific Sessions conversation on social media using #ADA2019.
About the American Diabetes Association
Every day more than 4,000 people are newly diagnosed with diabetes in America. Nearly 115 million Americans have diabetes or prediabetes and are striving to manage their lives while living with the disease. The American Diabetes Association (ADA) is the nation’s leading voluntary health organization fighting to bend the curve on the diabetes epidemic and help people living with diabetes thrive. For nearly 80 years the ADA has been driving discovery and research to treat, manage and prevent diabetes, while working relentlessly for a cure. We help people with diabetes thrive by fighting for their rights and developing programs, advocacy and education designed to improve their quality of life. Diabetes has brought us together. What we do next will make us Connected for Life. To learn more or to get involved, visit us at diabetes.org or call 1-800-DIABETES (1-800-342-2383). Information is available in English and Spanish. Join the fight with us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn).
# # #